Health

FDA Approves Sephience (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria

DailyTrendDailyTrend
Jul 29, 2025 - 14:00
 0  0
FDA Approves Sephience (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria
WARREN, N.J., July 28, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the U.S. Food and Drug Administration (FDA) has approved Sephience™ (sepiapterin) for the treatment of children and adults living with...
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
DailyTrend
DailyTrend

Related Posts

FDA Approves Skytrofa (lonapegsomatropin-tcgd) for the Once-Weekly Treatment of Adults with Growth Hormone Deficiency

FDA Approves Skytrofa (lonapegsomatropin-tcgd) for the ...

DailyTrend Jul 29, 2025  0  0

UnitedHealth Grew to Be a Leviathan. Then Came the Backlash.

UnitedHealth Grew to Be a Leviathan. Then Came the Back...

DailyTrend Jul 28, 2025  0  0

Arterial Cannula Recall: Edwards Lifesciences Removes Arterial Cannula due to Risk of Wire Exposure

Arterial Cannula Recall: Edwards Lifesciences Removes A...

DailyTrend Jul 25, 2025  0  0

Timeless Advice From Couples Counselors

Timeless Advice From Couples Counselors

DailyTrend Jul 26, 2025  0  0

RFK Jr. Announces Plan to Restrict Opioid-Like Kratom Product

RFK Jr. Announces Plan to Restrict Opioid-Like Kratom P...

DailyTrend Jul 29, 2025  0  0

C.D.C. Ties 85 Cases of THC-Related Symptoms to Wiscons...

DailyTrend Jul 28, 2025  0  0